意大利CDMO企业Flamma富乐马集团将加盟NDC 2024生物医药创新博览会，分享国际化经验！
演讲者：
Flamma S.p.A. - Italy R&D Project Manager Beatrice Trucchi
演讲主题：
Nucleosidic phosphoramidites: an optimized approach in their synthesis, quality evaluation and impurities characterization
< Flamma Group introduction >
富乐马是一家意大利家族企业，1950年创建于意大利贝加莫。
富乐马多次获得CDMO相关奖项，为医药和生物科技行业生产供应API和高级中间体。
富乐马全球有5处工厂，3处位于意大利，1处位于中国大连，1处位于美国。我们在中国在新建工厂来扩大我们的业务体量来更好的服务客户。我们的计划是增加在中国市场业务。
我们每个项目，无论项目体量大小，相关的业务开发方法符合客户的期待，此举为建立积极，有意义的长期合作关系。
通过协调客户和公司的利益，富乐马将我们的专业知识与创新和激情相结合。当您选择API开发和制造合作伙伴时，富乐马希望成为您的首选。
Flamma is an Italian family-owned company founded in 1950,
in Bergamo
, Italy.
Flamma is an award winning CDMO that manufactures active ingredients and advanced intermediates for the pharmaceutical and biotech industries.
Flamma has total 5 plants, 3 in Italy, 1 in Dalian of China and 1 in US.
In China, we are building a new plant to expand our capacity to serve for our customers, the new plant will start to operate first half of 2025. Our plan is to increase our presence in China.
Our business development approach meets the expectations of our customers for each project, regardless of size, in order to build a positive,
rewarding
& lasting relationship.
By harmonizing customer & company interests, Flamma leverages our expertise with innovation & passion. Flamma wants to be your first choice when you select a partner
for API development & manufacturing.
< Flamma Honkai (China) >
提供小分子药物CDMO及商业化原料药，肽，氨基酸，杂环类等产品供应；
公斤级实验室, 设备体积至50升反应器；中试车间，200-500升反应釜商业化规模：1000-10000L反应釜。可承接公斤级至吨位项目生产。
▲富乐马鸿凯一期工程
